News
Telix Pharmaceuticals’ Illuccix gets US FDA label expansion to add patient selection for radioligand therapy: Melbourne, Australia Wednesday, June 25, 2025, 17:00 Hrs [IST] Melb ...
MELBOURNE, Australia and INDIANAPOLIS, June 25, 2025 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix", "the Company") today announces that its Telix Manufacturing ...
GlobalData on MSN2d
Telix launches new PET radiochemistry solutionTelix Pharmaceuticals has introduced a new positron emission tomography (PET) radiochemistry solution, AlFluor.
Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”, “the Company”) today announces that the United States (U.S.) ...
TipRanks on MSN7d
Telix Pharmaceuticals Updates Director’s Interest in SecuritiesTelix Pharmaceuticals ( ($AU:TLX) ) has shared an update. Telix Pharmaceuticals has announced a change in the director’s interest, specifically ...
Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”, “the Company”) today announces five abstract presentations and ...
Telix Investor Day in New York City on June 11, 2025: Presenting KOLs. MELBOURNE, Australia and INDIANAPOLIS, June 03, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX ...
Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”, “the Company”) today announces that its next-generation ...
Stockhead on MSN9h
Health Check: UBS turns ultra-bullish on Aussie healthcare leadersUBS reckons healthcare will fare better than any other ASX sector Bell Potter says Monash IVF has fertile recovery prospects ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback